Marksans operates with a strategic and distinctive model to achieve its vision of establishing a globally respected, profitable, and integrated pharmaceutical company. Our focus extends to generic pharmaceutical formulation research, manufacturing, and marketing, supported by four state-of-the-art facilities located in India, the United Kingdom, and the United States. Through an unwavering commitment to Quality Control (QC) and Quality Assurance (QA), we have successfully carved out a distinctive niche within the pharmaceutical ecosystem where we operate.
Quality is at the core of our operations, and we are fully compliant with benchmark industry standards and regulations such as
- US Food and Drug Administration (US FDA)
- Therapeutic Goods Administration (TGA), Australia
- Medicines and Healthcare products Regulatory Agency (MHRA), UK
- EU Health Authority
- Health Canada
- Japanese Health Authority in Accreditations